Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(17 sites)
United States
Arizona Oncology Associates, Tucson, Arizona Colorado Blood Cancer Institute, Denver, Colorado Rocky Mountain Cancer Center, Denver, Colorado Medical Oncology Hematology Consultants, Newark, Delaware Florida Cancer Specialists, Lake Mary, Florida Maryland Oncology Hematology, Columbia, Maryland Minnesota Oncology Hematology, Minneapolis, Minnesota Virginia Oncology Associates, Elizabeth City, North Carolina Oncology Hematology Care, Cincinnati, Ohio Oncology Associates of Oregon, Eugene, Oregon TriStar Bone Marrow Transplant, Nashville, Tennessee Vanderbilt- Ingram Cancer Center, Nashville, Tennessee Texas Oncology, Austin, Texas Texas Oncology - San Antonio, San Antonio, Texas Texas Oncology - Northeast Texas, Tyler, Texas Virginia Cancer Specialists, Fairfax, Virginia Blue Ridge Cancer Center, Roanoke, Virginia Last updated February 2026